Incidence of acute myocardial infarction and cause-specific mortality after transurethral treatments of prostatic hypertrophy

Weisman, Kenneth; Larijani, Ghassem E.; Goldberg, Michael E.

doi:10.1016/s0090-4295(00)00708-1

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 31 Weisman et al found that the incidence of AMI and cardiovascular death in patients with BPH after surgery was significantly higher than that in non-surgical patients. 12 , 32 In this study, we investigated 146 patients with BPH, including 33 patients with CAD (incidence rate: 22.6%).…”

Section: Discussionmentioning

confidence: 99%

Evaluation of efficacy and safety of improved transurethral plasma kinetic enucleation of the prostate in high-risk patients with benign prostatic hyperplasia and coronary artery disease

Meng

et al. 2021

J Int Med Res

View full text Add to dashboard Cite

Objective This prospective study aimed to evaluate the safety of improved transurethral plasma kinetic enucleation of the prostate (iTUPKEP) in the perioperative period in high-risk patients with benign prostatic hyperplasia (BPH) and coronary artery disease. Methods Patients with BPH underwent surgical treatment with transurethral vapour resection of the prostate (TUVP) or iTUPKEP. Serum endothelin-1, cardiac troponin-I, and high-sensitivity C-reactive protein concentrations were evaluated in the short term after surgery. The postvoid residual urine volume, maximum urinary flow rate, international prostate symptom score, and quality of life indicators were evaluated in the long term after surgery. Results Endothelin-1 concentrations were lower in the iTUPKEP group than in the TUVP group at 1 and 2 days postoperatively. The iTUPKEP group had lower cardiac troponin-I and high-sensitivity C-reactive protein concentrations at all time points postoperatively. The postvoid residual urine volume, international prostate symptom score, and quality of life values were lower, but the maximum urinary flow rate was higher, in the iTUPKEP group than in the TUVP group. Conclusions The iTUPKEP procedure has a smaller effect on vascular endothelial function compared with TUVP. Therefore, iTUPKEP may reduce the incidence of postoperative cardiovascular adverse events in high-risk patients with BPH and coronary artery disease.

show abstract

Section: Discussionmentioning

confidence: 99%